This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 COVID-19 Beneficiary Stocks at All-Time High: ETFs to Buy
by Sanghamitra Saha
The tech sector???s rally has known no bound in recent weeks as the contagion is mandating social distancing and boosting the appeal for work-learn-play from home.
10 Power-Packed ETFs to Buy for Second-Half 2020
by Sweta Killa
We have highlighted a pack of ETFs that are poised to outperform in the second half.
Top ETF Stories of 1H Likely to Rule in Second-Half 2020
by Sanghamitra Saha
Overall, the S&P 500 is down 1.6% this year (as of Jul 6, 2020) while the Nasdaq Composite has gained 16.3% in the year-to-date frame. The Dow Jones has suffered the most with 7.9% year-to-date loss.
ETFs to Ride the Wave of 3 Key Coronavirus-Led Trends in 2H20
by Sweta Jaiswal, FRM
It seems like the 'new normal' trends are here to stay in the second half of 2020 as the coronavirus outbreak continues to aggravate with a second wave.
4 Best ETF Areas of Q2
by Sanghamitra Saha
Global stocks rallied in Q2 despite lockdowns and a standstill economic recovery.
Try These ETF Areas in Virus-Impacted Second Half of 2020
by Sweta Jaiswal, FRM
Here we highlight a few ETF areas that have the potential to do well in the second half of this year amid the coronavirus crisis.
The Zacks Analyst Blog Highlights: FCG, WCLD, BUYZ, IBUY and LRNZ
by Zacks Equity Research
The Zacks Analyst Blog Highlights: FCG, WCLD, BUYZ, IBUY and LRNZ
5 ETFs That Outshined During 100 Days of Coronavirus Pandemic
by Sweta Killa
While every sector of the market has rallied, information technology and consumer discretionary has been the clear winner during the pandemic.
Fearing 2nd Wave of Coronavirus? Bet on Stay-at-Home ETFs
by Sweta Jaiswal, FRM
Here we highlight a few ETF areas that have the potential to do well if the second wave of coronavirus infections hit the United States.
Is it Time to Buy Cannabis Stocks & ETFs?
by Neena Mishra
CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.